VVC Bites
All bites
Series CHealthtech·NotableSignal 72 · US market

Forus Raises $150M Series C at $3B Valuation

Company
Forus
Funding stage
Series C
Amount
$150 million
Date
Location
🇺🇸 the US
Sector
Healthcare Automation
Investors
Bain Capital Ventures, Accel, Thrive Capital, General Catalyst, Redpoint Ventures, BoxGroup, Pear VC

What happened

Healthcare automation startup Forus raised $150 million in a Series C funding round at a $3 billion valuation. Bain Capital Ventures led the investment, with participation from Accel, Thrive Capital, General Catalyst, Redpoint Ventures, BoxGroup, and Pear VC.

Why it matters

Bain Capital Ventures leading alongside a syndicate of top-tier funds demonstrates strong conviction in healthcare automation scaling into multi-billion-dollar outcomes. A $3B valuation at Series C sets a high benchmark for healthtech software platforms automating operational workflows.

What to watch

Watch whether Forus can expand contract sizes across major hospital networks to justify its premium valuation.

VCBites Signal

76/ 100
Major signal

Why this score: A $150M Series C led by Bain Capital Ventures at a $3B valuation, backed by top-tier firms including Accel and Thrive Capital, represents a landmark mega-round for healthtech.

VCBites' internal significance rating (0-100) — our editorial read, not a market-standard metric. VC Bites' assessment of the significance of this development to the venture ecosystem. Not investment advice.

Who should care?

  • Healthtech Founders
  • VC Investors
  • Healthcare Executives
  • Growth Investors

Source

This is an original short summary. Read the full reporting at the original source.

Read the original story on Bloomberg

Share the signal

VC Bites

Forus Raises $150M Series C at $3B Valuation

VCBITES SIGNAL: 76 / 100

Why it matters

Bain Capital Ventures leading alongside a syndicate of top-tier funds demonstrates strong conviction in healthcare automation scaling into multi-billion-dollar outcomes. A $3B valuation at Series C sets a high benchmark for healthtech software platforms automating operational workflows.

VC Bites · Venture capital signals, explained.

The post text is copied to your clipboard so you can paste it alongside the link.

More Healthtech bites

UndisclosedHealthtechUS·NewNotableSignal 72 · US market

Fortell raises $163M for AI hearing aids

AI hearing aid startup Fortell raised $163 million in new funding. The round included investments from Founders Fund, Thrive Capital, and Valor Equity.

Why it matters

High-conviction backing from Founders Fund and Thrive Capital points to growing venture appetites for consumer medical hardware augmented by AI edge processing. Applying AI to legacy hearing aid tech creates a potential bridge between medical devices and high-margin consumer electronics.

What to watch

Regulatory progress and distribution channels as Fortell transitions from funding to commercial market rollout.

Read biteSource · TechCrunch
UndisclosedHealthtechUS·NewNotableSignal 73 · US market

Fortell raises $163M for AI hearing aids

AI hearing aid startup Fortell raised $163 million in funding. The round included participation from Founders Fund, Thrive Capital, and Valor Equity.

Why it matters

Backing from Founders Fund, Thrive Capital, and Valor Equity for a $163 million round signals strong venture alignment around AI-enhanced medical hardware. Premium software funds entering specialized audio hardware shows appetite for defensible consumer health devices.

What to watch

Track regulatory approvals, manufacturing scaling, and early consumer adoption rates for Fortell's device launch.

Read biteSource · TechCrunch
OtherHealthtechCanada·BackgroundSignal 26 · Canada market

Grey Matters Increases Private Placement to CAD $1.1M

Grey Matters Health Inc. announced an increase and change to its non-brokered equity and convertible debenture private placement to CAD $1.1 million. The Canadian healthcare company is listed on the CSE.

Why it matters

Small-scale equity and convertible debt top-ups on public exchanges like the CSE signal cash preservation over rapid expansion. Micro-placements of this size demonstrate constrained institutional appetite for early-stage public healthtech entities.

What to watch

Conversion terms of the debentures and net cash runway in upcoming filings.

Read biteSource · Financial Post